The Dow Jones is a list of big companies in the U.S. and their values go up and down every day. Today, they went up by more than 100 points which means those companies are worth more money now. The NASDAQ and S&P 500 are also lists of companies but different from the Dow Jones. They also went up today. One company called EyePoint Pharmaceuticals did not do well and its value went down a lot. Read from source...

- The title is misleading and sensationalized, implying that the performance of the entire stock market was dependent on EyePoint Pharmaceuticals. In reality, the Dow Jones index gained more than 100 points, which is a positive outcome for most investors.
- The article does not provide any context or explanation for why EyePoint Pharmaceuticals shares plunged, which could have been due to various factors unrelated to the overall market trend. This creates confusion and uncertainty for readers who are interested in understanding the reasons behind the stock price movement.
- The article focuses on Spirit Airlines (NYSE:SAVE) as a contrasting example of EyePoint Pharmaceuticals, but does not provide any analysis or comparison between the two companies. This makes the inclusion of Spirit Airlines irrelevant and confusing for readers who are looking for insights into how different sectors performed on that day.
- The article ends abruptly with a link to Benzinga Pro, which is a subscription service that offers advanced trading tools and market analysis. This seems like an advertisement or a promotional tactic rather than a genuine attempt to provide value to readers who are interested in learning more about the stock market.

Given the current market conditions and the performance of various sectors, I would suggest the following portfolio allocation for a moderately aggressive investor:

- 40% in technology stocks, such as Apple Inc. (AAPL) or Microsoft Corporation (MSFT), which have strong growth prospects and are leaders in their respective fields. These stocks also offer dividends and capital appreciation potential.
- 30% in consumer discretionary stocks, such as Nike Inc. (NKE) or Starbucks Corporation (SBUX), which are expected to benefit from the reopening of the economy and increased consumer spending. These stocks also have strong brand recognition and loyal customer base.
- 20% in healthcare stocks, such as Johnson & Johnson (JNJ) or Pfizer Inc. (PFE), which are likely to benefit from the ongoing COVID-19 vaccine rollout and increasing demand for medical services. These stocks also offer dividends and dividend growth potential.
- 10% in energy stocks, such as Exxon Mobil Corporation (XOM) or Chevron Corporation (CVX), which are expected to benefit from the rising oil prices and increased demand for fossil fuels. These stocks also have strong balance sheets and dividend yields.